Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II

Phase 3 Completed 10 enrolled GWT-TUD GmbH Ardeypharm GmbH · collab

NaSingle-groupOpen-labelTreatment

Summary

This is a pilot study to investigate the effect of e.-coli-nissle as supporting therapy to antidiabetic standard care in patients with diabetes mellitus type II

Timeline

Start: 2014-08
Primary completion: 2016-01
Completion: 2016-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	E. coli Nissle	Unknown	1 ml	Oral

Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II

Summary

Timeline

Drugs

Indications